Growth Investing
Jim Cramer: Post-Snowflake Hangover Puts Easy-to-Understand Stocks Back on Map
Copper and gold producer Freeport-McMoRan serves an example of a dull but cheap stock that is finding investor favor again.
Cannabis Company Eyes Medicinal Magic of Mushrooms
Mydecine Innovations Group -- formerly known as NewLeaf -- signed an agreement with the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences.
If You Invest in Small-Cap Stocks, You've Got to Learn to Deal With Setbacks
Tivity Health's big price drop serves as an example of the thought process an investor must go through when a holding takes an unexpected hit.
3 Small Biotechs With Potential Catalysts at Hand
Esperion Therapeutics, Agenus Inc. and Baudax Bio could see coming events trigger positive reactions in their shares.
Bloomin' Brands Finds Activist Rattling Its Saber Again
Jana Partners indicates its plans to nominate a few director candidates to the restaurant operator's board.
This Contrarian Play Is My Pick of the Year for 2020
The antibiotics maker recently received a significant federal contract that could help give its shares the juice they need to climb next year.
3 Tech Themes That Played Out In 2019
The trio involves unicorns, the FAANG stocks and blockchain.
Novocure's Charts Are as Bullish As They Get, So Here's My Strategy
The oncology company has had a strong run and all the technical signals indicate the move higher isn't over.
Checking In on 2 Small Biotech Names That Had Big Quarters
Stemline Therapeutics and Flexion Therapeutics both saw their shares climb on positive news developments.
Chart of the Day: Vetting the Value of Cannabis Companies
Assessing Aurora and its peers, strictly on the numbers.